Eckert & Ziegler Strahlen und Medizintechnik AG

ots Ad hoc-Service: Eckert & Ziegler AG Increase of Sales and Results at Eckert & Ziegler AG

The sender is solely responsible for the contents of this announcement. -----------------------------------------------------

    Berlin (ots Ad hoc-Service) -      
    
    Neue-Markt listed Eckert & Ziegler AG, a specialist for the
provision of miniaturized, low-level radiation sources for the
treatment of cancer and cardio- vascular diseases, increased its
pretax financial income by approximately 80% to 500,000 EUR and its
sales by 50% to 4,200,000 EUR in the first quarter of 2000 in
comparison to the last year's quarter. The total operating
performance, i.e. the sum of sales, changes in inventories, self
constructed assets and other operating income, climbed to 5,300,000
EUR (+ 50%). The sales growth was driven equally by all divisions
with the exception of the cardio-vascular segment (remedies against
arteriosclerotic blockage), where the market penetration, due to
local licensing delays and despite European regulatory approval, did
not materialize as quickly as anticipated. Sales here remained steady
by comparison with the prior-year period - (which had, however, been
quite strong). On the other hand, sales developments in the segments
"Other Medical" and "Oncology" were disproportionately high; that
includes especially calibration sources (37%) and cancer remedies
(brachytherapy sources and radioactive implants) (18%). In this
sector, the elimination of technical bottle-necks and the resulting
capacity expansion of the subsidiary, BEBIG Isotopentechnik und
Umweltdiagnostik GmbH, Berlin, were notable. As in the past, Eckert &
Ziegler AG in the first quarter of 2000 continued to realize the bulk
of its sales, some 60%, from American customers. The strong global
position of the American medical appliance industry has made it
possible for Eckert & Ziegler AG to invoice products reimported to
Europe in U.S. dollars, and thus to profit from the increase in value
of this currency vis- a-vis that of the euro.

    The Board of Directors

    For further information please contact: Dr. Andreas Eckert CEO and President Eckert & Ziegler AG Robert-Rössle-Str. 10 D-13125 Berlin Tel.: (+ 49 30) 94 10 84 - 0 Fax: (+ 49 30) 94 10 84 - 112 http://www.ezag.de

End ----------------------------------------------------- Internet: http://recherche.newsaktuell.de

Original-Content von: Eckert & Ziegler Strahlen und Medizintechnik AG, übermittelt durch news aktuell

Weitere Meldungen: Eckert & Ziegler Strahlen und Medizintechnik AG

Das könnte Sie auch interessieren: